Hypoxic tumor therapy by hemoglobin-mediated drug delivery and reversal of hypoxia-induced chemoresistance.
Yang J, Li W, Luo L, Jiang M, Zhu C, Qin B, Yin H, Yuan X, Yin X, Zhang J, Luo Z, Du Y, You J.
Yang J, et al. Among authors: yin h, yin x.
Biomaterials. 2018 Nov;182:145-156. doi: 10.1016/j.biomaterials.2018.08.004. Epub 2018 Aug 11.
Biomaterials. 2018.
PMID: 30121013